Talk:Pegaptanib

Discovery by Gilead Disputed
I believe that it was actually NeXstar (founded by Larry Gold and Craig Tuerk) was the original discoverer. As Gilead didn't acquire NeXstar until 1999 -- a decade after Gold and Tuerk's work -- they shouldn't be credited.

http://www.epo.org/learning-events/european-inventor/finalists/2006/Gold.html

Daen (talk) 00:32, 4 June 2013 (UTC)

Patent expiry
US patents 6,113,906 and 5,919,455 on pegaptanib sodium expired around end October 2013. US patents 6,051,698, and 6,011,020, expire in 2015, & 2017. - Rod57 (talk) 06:20, 12 September 2015 (UTC)
 * US patent 5,932,462 expired Aug 3, 2016. - Rod57 (talk) 09:14, 4 August 2016 (UTC)

Strange results from 2 'identical' phase 3 trials
It says the two phase 3 studies were identical but the 2nd year results are very different. What explanations have been given ? - Rod57 (talk) 09:11, 4 August 2016 (UTC)